Replies to post #455082 on Anavex Life Sciences Corp (AVXL)

[crescentmotor]

This drop is no different than any other pressure drop prior to a successful buyout by a large pharma.

What's different in AVXL's case is that, for the time being, the drastic drop in the stock price will attract nothing but a lowball buyout price. I further suspect that the low stock price means Missling would have no leverage in any partnership discussions.

Its also very likely the low institutional ownership is in large part due to no secondaries being offered

That may be true as a partial explanation. Nevertheless, it is what it is and AVXL does not have much needed institutional support to help defend the stock price.